Molecular and biochemical markers in colorectal cancer

被引：32

作者：

McDermott, U ^{[1
]}

Longley, DB ^{[1
]}

Johnston, PG ^{[1
]}

机构：

[1] Queens Univ Belfast, Canc Res Ctr, Dept Oncol, Belfast, Antrim, North Ireland

来源：

ANNALS OF ONCOLOGY | 2002年 / 13卷

关键词：

D O I：

10.1093/annonc/mdf665

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：235 / 245

页数：11

共 102 条

[1] Eniluracil treatment completely inactivates dihydropyrimidine dehydrogenase in colorectal tumors [J].

Ahmed, FY ;

Johnston, SJ ;

Cassidy, J ;

O'Kelly, T ;

Binnie, N ;

Murray, GI ;

van Gennip, AH ;

Abeling, NGGM ;

Knight, S ;

McLeod, HL .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) :2439-2445

[2]

Ahnen DJ, 1998, CANCER RES, V58, P1149

[3] Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer [J].

Allegra, CJ ;

Parr, AL ;

Wold, LE ;

Mahoney, MR ;

Sargent, DJ ;

Johnston, P ;

Klein, P ;

Behan, K ;

O'Connell, MJ ;

Levitt, R ;

Kugler, JW ;

Tirona, MT ;

Goldberg, RM .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) :1735-1743

[4] K-ras mutations and prognosis in large-bowel carcinomas [J].

Andersen, SN ;

Lovig, T ;

Breivik, J ;

Lund, E ;

Gaudernack, G ;

Meling, GI ;

Rognum, TO .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1997, 32 (01) :62-69

[5] Kirsten ras mutations in patients with colorectal cancer:: the 'RASCAL II' study [J].

Andreyev, HJN ;

Norman, AR ;

Cunningham, D ;

Oates, J ;

Dix, BR ;

Iacopetta, BJ ;

Young, J ;

Walsh, T ;

Ward, R ;

Hawkins, N ;

Beranek, M ;

Jandik, P ;

Benamouzig, R ;

Jullian, E ;

Laurent-Puig, P ;

Olschwang, S ;

Muller, O ;

Hoffmann, I ;

Rabes, HM ;

Zietz, C ;

Troungos, C ;

Valavanis, C ;

Yuen, ST ;

Ho, JWC ;

Croke, CT ;

O'Donoghue, DP ;

Giaretti, W ;

Rapallo, A ;

Russo, A ;

Bazan, V ;

Tanaka, M ;

Omura, K ;

Azuma, T ;

Ohkusa, T ;

Fujimori, T ;

Ono, Y ;

Pauly, M ;

Faber, C ;

Glaesener, R ;

de Goeij, AFPM ;

Arends, JW ;

Andersen, SN ;

Lövig, T ;

Breivik, J ;

Gaudernack, G ;

Clausen, OPF ;

De Angelis, P ;

Meling, GI ;

Rognum, TO ;

Smith, R .

BRITISH JOURNAL OF CANCER, 2001, 85 (05) :692-696

[6] Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy [J].

Aschele, C ;

Debernardis, D ;

Casazza, S ;

Antonelli, G ;

Tunesi, G ;

Baldo, C ;

Lionetto, R ;

Maley, F ;

Sobrero, A .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) :1760-1770

[7] Enhanced phosphorylation of p53 by ATN in response to DNA damage [J].

Banin, S ;

Moyal, L ;

Shieh, SY ;

Taya, Y ;

Anderson, CW ;

Chessa, L ;

Smorodinsky, NI ;

Prives, C ;

Reiss, Y ;

Shiloh, Y ;

Ziv, Y .

SCIENCE, 1998, 281 (5383) :1674-1677

[8] A ROLE FOR DIHYDROPYRIMIDINE DEHYDROGENASE AND THYMIDYLATE SYNTHASE IN TUMOR SENSITIVITY TO FLUOROURACIL [J].

BECK, A ;

ETIENNE, MC ;

CHERADAME, S ;

FISCHEL, JL ;

FORMENTO, P ;

RENEE, N ;

MILANO, G .

EUROPEAN JOURNAL OF CANCER, 1994, 30A (10) :1517-1522

[9] PROGNOSTIC VALUE OF P53 OVEREXPRESSION AND C-KI-RAS GENE-MUTATIONS IN COLORECTAL-CANCER [J].

BELL, SM ;

SCOTT, N ;

CROSS, D ;

SAGAR, P ;

LEWIS, FA ;

BLAIR, GE ;

TAYLOR, GR ;

DIXON, MF ;

QUIRKE, P .

GASTROENTEROLOGY, 1993, 104 (01) :57-64

[10]

Boland CR, 1998, CANCER RES, V58, P5248

← 1 2 3 4 5 6 7 8 9 10 →